Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Bibliographic Details
Main Authors:	Bradbury, C, Ward, J, Vyas, P, Russell, N, David, G, Hills, R, Burnett, A, Craddock, C, Sylvie, F
Format:	Conference item
Published:	2012

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Allogeneic Hematopoietic Cell Transplantation
by: Bradbury, C, et al.
Published: (2012)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
by: Vyas, P, et al.
Published: (2015)

Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation
by: Wen Yao, et al.
Published: (2022-02-01)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
by: Rafiye Çiftçiler, et al.
Published: (2019-05-01)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
by: Erden Atilla, et al.
Published: (2017-02-01)

P569: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PREGNANT WOMEN WITH ACUTE MYELOID LEUKEMIA
by: Vera Troitskaya, et al.
Published: (2023-08-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Enrico Maffini, et al.
Published: (2022-11-01)

Reduced Intensity versus Full Myeloablative Conditioning in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
by: Kamran Alimoghaddam, et al.
Published: (2011-09-01)

Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation presenting as pericardial effusion
by: Yuyan Shen, et al.
Published: (2023-10-01)

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response
by: K. H. Begna, et al.
Published: (2022-01-01)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
by: Michael M. B. Green, et al.
Published: (2016-08-01)

Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
by: LIN Shijia, et al.
Published: (2019-12-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
by: Xing-yu Cao, et al.
Published: (2023-12-01)

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
by: Jodi J. Lipof, et al.
Published: (2018-06-01)

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: E. Gavriilaki, et al.
Published: (2022-06-01)

Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
by: Hamilton Betty K, et al.
Published: (2013-01-01)

Normal hematopoietic progenitor subsets have distinct reactive oxygen species, BCL2 and cell-cycle profiles that are decoupled from maturation in acute myeloid leukemia
by: Khan, N, et al.
Published: (2016)

P1383: EXTRAMEDULLARY RELAPSE OF ACUTE MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE
by: F. Vasconcelos, et al.
Published: (2022-06-01)

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Yasmine Kadri, et al.
Published: (2022-08-01)

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
by: Justin Loke, et al.
Published: (2021-05-01)

Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation
by: Desiree Kunadt, et al.
Published: (2022-08-01)

Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Takahiro Kumode, et al.
Published: (2020-01-01)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
by: Simona Pagliuca, et al.
Published: (2023-05-01)

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation
by: Ferguson, P, et al.
Published: (2016)

Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation
by: Maite Alvarez, et al.
Published: (2021-01-01)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
by: Elizabeth A de Kort, et al.
Published: (2019-01-01)

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
by: Quek, L, et al.
Published: (2016)

P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY MULTIPARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: Maximilian Roehnert, et al.
Published: (2023-08-01)

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
by: Liu Hui, et al.
Published: (2013-02-01)

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
by: Shohei Mizuno, et al.
Published: (2024-04-01)

Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
by: Li Xuan, et al.
Published: (2021-01-01)

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
by: Christina Rautenberg, et al.
Published: (2020-08-01)

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
by: Yimei Feng, et al.
Published: (2023-06-01)

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
by: Harinder Gill, et al.
Published: (2020-05-01)

Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein–Barr virus infection
by: Yanhui Luo, et al.
Published: (2022-12-01)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
by: Cindy M. Pabon, et al.
Published: (2021-05-01)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
by: Carmine Liberatore, et al.
Published: (2022-06-01)

Relapse Following Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Apparently Due to Somatic Cell Evolution via Epigenetic Variation and Immune Selection
by: Neil S. Greenspan
Published: (2019-02-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
by: Gabriele Magliano, et al.
Published: (2020-10-01)

A Survey of Infection in Allogenic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
by: S R Safayi, et al.
Published: (2018-08-01)

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Similar Items

Similar Items